BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piepoli MF, Adamo M, Barison A, Bestetti RB, Biegus J, Böehm M, Butler J, Carapetis J, Ceconi C, Chioncel O, Coats A, Crespo-Leiro MG, de Simone G, Drexel H, Emdin M, Farmakis D, Halle M, Heymans S, Jaarsma T, Jankowska E, Lainscak M, Lam CSP, Løchen ML, Lopatin Y, Maggioni A, Matrone B, Metra M, Noonan K, Pina I, Prescott E, Rosano G, Seferovic PM, Sliwa K, Stewart S, Uijl A, Vaartjes I, Vermeulen R, Monique Verschuren WM, Volterrani M, Von Heahling S, Hoes A. Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology. Eur J Heart Fail 2022;24:143-68. [PMID: 35083829 DOI: 10.1002/ejhf.2351] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Cai A, Chen R, Pang C, Liu H, Zhou Y, Chen J, Li L. Machine learning model for predicting 1-year and 3-year all-cause mortality in ischemic heart failure patients. Postgrad Med 2022. [PMID: 35984114 DOI: 10.1080/00325481.2022.2115735] [Reference Citation Analysis]
2 Young KA, Scott CG, Rodeheffer RJ, Chen HH. Incidence of Preclinical Heart Failure in a Community Population. J Am Heart Assoc 2022;:e025519. [PMID: 35862175 DOI: 10.1161/JAHA.122.025519] [Reference Citation Analysis]
3 Tomasoni D, Adamo M, Metra M. July 2022 at a glance: focus on prognosis, devices and valvular heart disease. Eur J Heart Fail 2022;24:1145-7. [PMID: 35864809 DOI: 10.1002/ejhf.2234] [Reference Citation Analysis]
4 Chandramouli C, Stewart S, Almahmeed W, Lam CSP. Clinical implications of the universal definition for the prevention and treatment of heart failure. Clin Cardiol 2022;45 Suppl 1:S2-S12. [PMID: 35789016 DOI: 10.1002/clc.23842] [Reference Citation Analysis]
5 Hammond MM, Everitt IK, Khan SS. New strategies and therapies for the prevention of heart failure in high-risk patients. Clin Cardiol 2022;45 Suppl 1:S13-25. [PMID: 35789013 DOI: 10.1002/clc.23839] [Reference Citation Analysis]
6 Hofer F, Pailer U, Sulzgruber P, Gerges C, Winter MP, Giugliano RP, Gottsauner-Wolf M, Hülsmann M, Kazem N, Koller L, Schönbauer R, Niessner A, Hengstenberg C, Zelniker TA. Relationship of diabetes, heart failure, and N-terminal pro-B-type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation. ESC Heart Fail 2022. [PMID: 35593128 DOI: 10.1002/ehf2.13930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kobalava ZD, Safarova AF, Gudieva KM, Markova MA, Petrosyan AE. Comparative Efficacy of Single Pill Combinations of Azilsartan Medoxomil/Chlorthalidone and Losartan/Hydrochlorothiazide in Patients with Hypertension and Heart Failure with Preserved Ejection Fraction. Racionalʹnaâ farmakoterapiâ v kardiologii 2022;18:127-34. [DOI: 10.20996/1819-6446-2022-04-01] [Reference Citation Analysis]
8 Tomasoni D, Adamo M, Metra M. March 2022 at a glance: focus on medical therapy, prevention and comorbidities. Eur J Heart Fail 2022;24:403-5. [PMID: 35384200 DOI: 10.1002/ejhf.2226] [Reference Citation Analysis]
9 Stewart S, Stewart AR, Waite L, Beilby J. Out with the Old and In with the New: Primary Care Management of Heart Failure with Preserved Ejection Fraction. Card Fail Rev 2022;8:e04. [DOI: 10.15420/cfr.2021.27] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]